Italia

11 nuovi farmaci in commercio

Nuove specialitÓ medicinali:Fusicutanbeta, Takhzyro, Trusopt, Vivotif. 6 Nuovi farmaci equivalenti

Nuove specialità medicinali
FUSICUTANBETA crema 30 g 20 mg + 1 mg/g acido fusidico/betametasone valerato
MIBE PHARMA AIC:045358037 12,70€ C/RR in commercio dal:25/05/2020

FUSICUTANBETA crema 60 g 20 mg + 1 mg/g acido fusidico/betametasone valerato
MIBE PHARMA AIC:045358049 18,80€ C/RR in commercio dal:25/05/2020

TAKHZYRO SC 1 flaconcino 2 ml 300 mg lanadelumab
SHIRE PHARMACEUT. IRELAND LTD AIC:047417011 23.379,57€ A/RR in commercio dal:29/05/2020

TRUSOPT 1 flaconcino 5 ml 2% dorzolamide cloridrato
SANTEN AIC:031848056 7,88€ A/RR in commercio dal:27/05/2020

VIVOTIF 3 cps gastrores 2000 mln vaccino tifoideo vivo uso orale
EMERGENT AIC:045650013 27,20€ C/RR in commercio dal:20/05/2020

Nuovi farmaci equivalenti
DAPTOMICINA XELLIA 1 flaconcino polv 500 mg daptomicina
XELLIA PHARMACEUTICALS ApS AIC:045055035 118,50€ H/OSP in commercio dal:29/05/2020

FULVESTRANT EVER PHARMA IM 1 siringa 5 ml 250 mg fulvestrant
EVER VALINJECT GmbH AIC:046910016 470,68€ H/RNRL in commercio dal:20/05/2020

PROMAZINA EG 1 flaconcino 30 ml 4 g/100 ml promazina cloridrato
EG AIC:044108013 10,80€ C/RR in commercio dal:19/05/2020

SIMVASTATINA HEXAL 28 cpr 10 mg simvastatina
SANDOZ AIC:037213079 2,68€ A/RR in commercio dal:22/05/2020

SIMVASTATINA SANDOZ 28 cpr 10 mg simvastatina
SANDOZ AIC:037206036 2,68€ A/RR in commercio dal:22/05/2020

VERIZINA 50 cpr 20 mg + 40 mg cinnarizina/dimenidrinato
STEWART AIC:044185027 26,00€ Cnn / RR in commercio dal:01/06/2020

SEZIONE DOWNLOAD